PULMONARY FIBROSIS FOUNDATION: Form 990, tax year 2019

View the entire original 990 at ProPublica ↗

Organization
PULMONARY FIBROSIS FOUNDATION (EIN 84-1558631)
Tax period
2019-07-01 to 2020-06-30
Filed
2021-04-15
IRS object ID
202121059349301127
Schema version
2019v5.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2021-04-15T10:08:30-05:00ReturnTs
Tax Period End2020-06-30TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1BDO USA LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line19500 Bryn Mawr Ave Suite 300AddressLine1Txt
CityRosemontCityNm
State AbbreviationILStateAbbreviationCd
ZIP60018ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2019-07-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN841558631EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1Pulmonary Fibrosis FoundationBusinessNameLine1Txt
FieldValueIRS element (for citing)
In Care Of% SCOTT STASZAK COOInCareOfNm
Business Name ControlPULMBusinessNameControlTxt
Phone3122652182PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1230 East Ohio Street Suite 500AddressLine1Txt
CityChicagoCityNm
State AbbreviationILStateAbbreviationCd
ZIP606113270ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonSCOTT STASZAKPersonNm
Person TitleCOOPersonTitleTxt
Phone3125879272PhoneNum
Signature2021-04-13SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonJacob CookPreparerPersonNm
PTINP01240455PTIN
Phone8476762000PhoneNum
FieldValueIRS element (for citing)
Tax2019TaxYr
Build TS2022-09-23 18:48:47ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerSCOTT STASZAKPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1230 E Ohio Street Suite 500AddressLine1Txt
CityChicagoCityNm
State AbbreviationILStateAbbreviationCd
ZIP606113270ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$18,548,109GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website Addresswww.pulmonaryfibrosis.orgWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2000FormationYr
Legal Domicile StateCOLegalDomicileStateCd
Activity Or MissionTo mobilize people and resources to provide access to high-quality care and lead research for a cure so that people with pulmonary fibrosis will live longer, healthier lives.ActivityOrMissionDesc
Voting Members Governing Body11VotingMembersGoverningBodyCnt
Voting Members Independent11VotingMembersIndependentCnt
Total Employee40TotalEmployeeCnt
Total Volunteers1883TotalVolunteersCnt
Total Gross UBI$2,000TotalGrossUBIAmt
PY Contributions Grants$8,449,631PYContributionsGrantsAmt
CY Contributions Grants$8,450,064CYContributionsGrantsAmt
PY Program Service Revenue$2,180,520PYProgramServiceRevenueAmt
CY Program Service Revenue$2,548,146CYProgramServiceRevenueAmt
PY Investment Income$275,682PYInvestmentIncomeAmt
CY Investment Income$293,084CYInvestmentIncomeAmt
PY Other Revenue-$457,148PYOtherRevenueAmt
CY Other Revenue-$589,250CYOtherRevenueAmt
PY Total Revenue$10,448,685PYTotalRevenueAmt
CY Total Revenue$10,702,044CYTotalRevenueAmt
PY Grants And Similar Paid$293,007PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$342,863CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$3,585,863PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$3,557,722CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$1,076,890CYTotalFundraisingExpenseAmt
PY Other Expenses$4,609,314PYOtherExpensesAmt
CY Other Expenses$7,391,038CYOtherExpensesAmt
PY Total Expenses$8,488,184PYTotalExpensesAmt
CY Total Expenses$11,291,623CYTotalExpensesAmt
PY Revenues Less Expenses$1,960,501PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$589,579CYRevenuesLessExpensesAmt
Total Assets BOY$10,914,467TotalAssetsBOYAmt
Total Assets EOY$10,892,804TotalAssetsEOYAmt
Total Liabilities BOY$2,850,718TotalLiabilitiesBOYAmt
Total Liabilities EOY$3,594,974TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$8,063,749NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$7,297,830NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTO MOBILIZE PEOPLE AND RESOURCES TO PROVIDE ACCESS TO HIGH-QUALITY CARE AND LEAD RESEARCH FOR A CURE SO THAT PEOPLE WITH PULMONARY FIBROSIS WILL LIVE LONGER, HEALTHIER LIVES.MissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$2,540,164ExpenseAmt
Revenue$172,700RevenueAmt
DescOutreach and Awareness: Total revenue recognized for the program was $2,423,701, which included contributions and sponsorships of $2,251,000 in addition to the program service revenue of $172,700. The PFF Ambassador Program empowers patients, caregivers, and health care professionals as spokespersons for the PF community on behalf of the PFF. PFF Ambassadors promote disease awareness, provide up-to-date information, and offer hope and inspiration to those affected by pulmonary fibrosis. PFF Ambassadors are available to speak at PFF Care Center Network events, support group meetings, fundraising events, (Continued on Schedule O)Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$2,137,834ExpenseAmt
Revenue$1,944,397RevenueAmt
DescPFF Patient Registry: Total revenue recognized for the program was $2,098,260, which included contributions and sponsorships of $153,863 in addition to the program service revenue of $1,944,397. The PFF Registry (Registry) is a research effort that brings together multiple stakeholders including patients, health care providers, and researchers to advance research and improve the quality of life of patients with pulmonary fibrosis (PF). The crux of the Registry is comprised of an electronic database of patient information on diagnosis, treatment, and quality of life that is deidentified (made anonymous) and (Continued on Schedule O)Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$1,201,863ExpenseAmt
Revenue$431,049RevenueAmt
DescPFF Summit: Total revenue recognized for the PFF Summit was $1,230,929, which included $636,508 in contributions and sponsorships received during the year or released from prior year receipts. PFF Summit 2019 is the PFF's biennial international health care conference on Pulmonary Fibrosis (PF). The goal of the PFF Summit is to foster a collaborative environment to improve education and awareness of PF and to identify new approaches to treat, and ultimately cure, this devastating disease. (Continued on Schedule O)Desc
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$3,171,740TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant$342,863TotalOtherProgSrvcGrantAmt
Total Program Service Expenses$9,051,601TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesYes (true)LobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Donor Rstr Or Quasi EndowmentsfalseDonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecfalseReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsfalseReportOtherAssetsInd
Report Other LiabilitiesYes (true)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (true)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (true)IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtfalseConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficefalseForeignOfficeInd
Foreign ActivitiesfalseForeignActivitiesInd
More Than5000 K To OrgfalseMoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingfalseProfessionalFundraisingInd
Fundraising ActivitiesYes (true)FundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsYes (true)GrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsfalseTaxExemptBondsInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingfalseLoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With35 Ctrl EntfalseBusinessRlnWith35CtrlEntInd
Deductible Non Cash ContriYes (true)DeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityfalseDisregardedEntityInd
Related EntityfalseRelatedEntityInd
Related Organization Ctrl EntfalseRelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document47IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee40EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (true)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (true)Form990TFiledInd
Foreign Financial AccountfalseForeignFinancialAccountInd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsYes (true)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (true)QuidProQuoContriDisclInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht PymtfalseSubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst IncfalseSubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members11GoverningBodyVotingMembersCnt
Independent Voting Member11IndependentVotingMemberCnt
Family Or Business RlnfalseFamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersfalseElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersfalseLocalChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherYes (true)CompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldDCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonSCOTT STASZAK COOPersonNm
Phone3122652182PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1230 EAST OHIO STREET SUITE 500AddressLine1Txt
CityCHICAGOCityNm
State AbbreviationILStateAbbreviationCd
ZIP60611ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (19 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtHighest Compensated EmployeeHighestCompensatedEmployeeIndKey EmployeeKeyEmployeeIndIndividual Trustee Or DirectorIndividualTrusteeOrDirectorInd
William T Schmidt
Director/President and CEO40.00.0Yes (X)$365,209$0$27,650
Scott Staszak
Chief Operating Officer40.00.0Yes (X)$260,064$0$19,000
Pauline Bianchi
Senior VP, Research & Programs40.00.0$210,160$0$26,927Yes (X)
Laura Sadler
Chief Marketing Officer40.00.0$172,997$0$9,619Yes (X)
Kerrie Trebonsky
VP, Finance40.00.0$131,368$0$30,393Yes (X)
Rex Edwards
VP, CCN & PFF Patient Registry40.00.0$144,586$0$16,225Yes (X)
Seth Klein
Sr Director, Development Ops40.00.0$145,227$0$13,503Yes (X)
Zoe Bubany
VP, Board & External Relations40.00.0$120,096$0$10,747Yes (X)
George Eliades
Chairman1.00.0Yes (X)$0$0$0Yes (X)
Colleen Attwell
Vice-Chair1.00.0Yes (X)$0$0$0Yes (X)
David McNinch
Vice-Chair1.00.0Yes (X)$0$0$0Yes (X)
Laurie Chandler CFP
Treasurer1.00.0Yes (X)$0$0$0Yes (X)
Terence Hales
Secretary1.00.0Yes (X)$0$0$0Yes (X)
Mike Henderson
Director1.00.0$0$0$0Yes (X)
Jeff Harris
Director1.00.0$0$0$0Yes (X)
Wendi Mason
Direcor1.00.0$0$0$0Yes (X)
Andy Limper
Director1.00.0$0$0$0Yes (X)
Barbara Murphy
Director1.00.0$0$0$0Yes (X)
Dana A Ball
Director1.00.0$0$0$0Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$1,549,707TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$154,064TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K8IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedfalseFormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp

Contractor Name ContractorName

FieldValueIRS element (for citing)
PersonDorothy Coyle RaclawPersonNm

Contractor Address ContractorAddress

US Address USAddress

FieldValueIRS element (for citing)
Address Line15855 N Kenneth AveAddressLine1Txt
CityCHICAGOCityNm
State AbbreviationILStateAbbreviationCd
ZIP60626ZIPCd
FieldValueIRS element (for citing)
ServicesMarketing ConsultingServicesDesc
Compensation$144,575CompensationAmt
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K1CntrctRcvdGreaterThan100KCnt
Fundraising$1,115,387FundraisingAmt
All Other Contributions$7,334,677AllOtherContributionsAmt
Noncash Contributions$1,965,513NoncashContributionsAmt
Total Contributions$8,450,064TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (4 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
PFF PATIENT REGISTRY900099$1,944,397$1,944,397
PFF SUMMIT900099$431,049$431,049
THERAPEUTICS NETWORK900099$125,225$125,225
STRATEGIC PARTNERSHIPS900099$47,475$47,475
FieldValueIRS element (for citing)
Total Program Service Revenue$2,548,146TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$257,033TotalRevenueColumnAmt
Exclusion$257,033ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$7,233,518SecuritiesAmt
Other$1,962OtherAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$7,197,467SecuritiesAmt
Other$1,962OtherAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$36,051SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$36,051TotalRevenueColumnAmt
Exclusion$36,051ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$44,315FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$1,115,387ContriRptFundraisingEventAmt
Fundraising Direct Expenses$640,858FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$596,543TotalRevenueColumnAmt
Exclusion-$596,543ExclusionAmt
FieldValueIRS element (for citing)
Gaming Gross Income$0GamingGrossIncomeAmt
Gaming Direct Expenses$0GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Gross Sales Of Inventory$11,069GrossSalesOfInventoryAmt
Cost Of Goods Sold$5,778CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$5,291TotalRevenueColumnAmt
Exclusion$5,291ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtUnrelated Business RevenueUnrelatedBusinessRevenueAmtExclusionExclusionAmt
ADVERTISING900099$2,000$2,000
MISCELLANEOUS900099$2$2
FieldValueIRS element (for citing)
Other Revenue Total$2,002OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$10,702,044TotalRevenueColumnAmt
Related Or Exempt Func Income$2,548,146RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$2,000UnrelatedBusinessRevenueAmt
Exclusion-$298,166ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$342,863TotalAmt
Program Services$342,863ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$866,871TotalAmt
Program Services$404,930ProgramServicesAmt
Management And General$182,764ManagementAndGeneralAmt
Fundraising$279,177FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$2,296,402TotalAmt
Program Services$1,396,434ProgramServicesAmt
Management And General$471,917ManagementAndGeneralAmt
Fundraising$428,051FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$28,680TotalAmt
Program Services$17,175ProgramServicesAmt
Management And General$8,709ManagementAndGeneralAmt
Fundraising$2,796FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$161,009TotalAmt
Program Services$80,274ProgramServicesAmt
Management And General$48,948ManagementAndGeneralAmt
Fundraising$31,787FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$204,760TotalAmt
Program Services$104,143ProgramServicesAmt
Management And General$56,745ManagementAndGeneralAmt
Fundraising$43,872FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$70,464TotalAmt
Management And General$70,464ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$25,269TotalAmt
Management And General$25,269ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$280,017TotalAmt
Program Services$280,017ProgramServicesAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$4,670,646TotalAmt
Program Services$4,432,858ProgramServicesAmt
Management And General$130,992ManagementAndGeneralAmt
Fundraising$106,796FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$166,003TotalAmt
Program Services$166,003ProgramServicesAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$243,802TotalAmt
Program Services$177,583ProgramServicesAmt
Management And General$19,986ManagementAndGeneralAmt
Fundraising$46,233FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$12,938TotalAmt
Program Services$7,016ProgramServicesAmt
Management And General$3,031ManagementAndGeneralAmt
Fundraising$2,891FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$224,415TotalAmt
Program Services$122,470ProgramServicesAmt
Management And General$51,435ManagementAndGeneralAmt
Fundraising$50,510FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$523,818TotalAmt
Program Services$483,619ProgramServicesAmt
Management And General$24,395ManagementAndGeneralAmt
Fundraising$15,804FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$7,537TotalAmt
Program Services$3,529ProgramServicesAmt
Management And General$2,567ManagementAndGeneralAmt
Fundraising$1,441FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$2,036TotalAmt
Management And General$2,036ManagementAndGeneralAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$51,223TotalAmt
Program Services$27,721ProgramServicesAmt
Management And General$16,282ManagementAndGeneralAmt
Fundraising$7,220FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$44,813TotalAmt
Program Services$24,411ProgramServicesAmt
Management And General$10,348ManagementAndGeneralAmt
Fundraising$10,054FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
EVENT EXPENSES$875,995$860,085$15,330$580
DUES/SUBSCRIPTIONS/REGISTRAT$33,694$21,982$11,272$440
SOFTWARE EXPENSES$335$0$335$0
OTHER EXPENSES$158,033$98,488$10,307$49,238

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$11,291,623TotalAmt
Program Services$9,051,601ProgramServicesAmt
Management And General$1,163,132ManagementAndGeneralAmt
Fundraising$1,076,890FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$221,577BOYAmt
EOY$483,720EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$3,975,907BOYAmt
EOY$4,670,786EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$1,166,592BOYAmt
EOY$55,718EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$33,997EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$223,507BOYAmt
EOY$137,343EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$223,703LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$180,713LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$69,870BOYAmt
EOY$42,990EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$4,710,031BOYAmt
EOY$4,863,723EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$99,963BOYAmt
EOY$172,896EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$447,020BOYAmt
EOY$431,631EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$10,914,467BOYAmt
EOY$10,892,804EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$1,406,425BOYAmt
EOY$1,523,757EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$104,311BOYAmt
EOY$300,000EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$1,327,306BOYAmt
EOY$1,207,629EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$560,300EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$12,676BOYAmt
EOY$3,288EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$2,850,718BOYAmt
EOY$3,594,974EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$3,871,039BOYAmt
EOY$4,012,393EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$4,192,710BOYAmt
EOY$3,285,437EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$8,063,749BOYAmt
EOY$7,297,830EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$10,914,467BOYAmt
EOY$10,892,804EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss-$589,579ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$176,340NetUnrlzdGainsLossesInvstAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredfalseFederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$5,558,537CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$5,775,504CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$5,989,047CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$8,449,631CurrentTaxYearMinus1YearAmt
Current Tax Year$8,450,064CurrentTaxYearAmt
Total$34,222,783TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$5,558,537CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$5,775,504CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$5,989,047CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$8,449,631CurrentTaxYearMinus1YearAmt
Current Tax Year$8,450,064CurrentTaxYearAmt
Total$34,222,783TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$14,561,195SubstantialContributorsTotAmt
Public Support Total170$19,661,588PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$14,534CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$11,635CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$69,969CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$273,967CurrentTaxYearMinus1YearAmt
Current Tax Year$257,033CurrentTaxYearAmt
Total$627,138TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$2,101CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,060CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$691CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$234CurrentTaxYearMinus1YearAmt
Current Tax Year$2CurrentTaxYearAmt
Total$4,088TotalAmt
FieldValueIRS element (for citing)
Total Support$34,854,009TotalSupportAmt
Gross Receipts Rltd Activities$11,720,813GrossReceiptsRltdActivitiesAmt
Public Support CY1700.56411PublicSupportCY170Pct
Public Support PY1700.57970PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE A, PART II, SECTION AFormAndLineReferenceDesc
ExplanationTHE ORGANIZATION CHANGED THEIR ACCOUNTING YEAR END FROM DECEMBER 31(CALENDAR YEAR) TO JUNE 30 (FISCAL YEAR) IN 2015. IN ACCORDANCE WITH THE INSTRUCTIONS, THE COLUMNS FOR YEARS 2015-2019 CORRESPOND TO THE 5 PRIOR TAX RETURNS FILED: 2015 = 2015 RETURN (6/30/2016 YEAR-END) 2016 = 2016 RETURN (6/30/2017 YEAR-END) 2017 = 2017 RETURN (6/30/2018 YEAR-END) 2018 = 2018 RETURN (6/30/2019 YEAR-END) 2019 = 2019 RETURN (6/30/2020 YEAR-END)ExplanationTxt

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$40,551FilingOrganizationsTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$239,466FilingOrganizationsTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$280,017FilingOrganizationsTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$8,771,584FilingOrganizationsTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$9,051,601FilingOrganizationsTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Filing Organizations Total$602,580FilingOrganizationsTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Filing Organizations Total$150,645FilingOrganizationsTotalAmt
FieldValueIRS element (for citing)
Tot Lbbyng Grassroot Mns Non TxTotLbbyngGrassrootMnsNonTxGrp
Tot Lbby Expend Mns Lbbyng Non TxTotLbbyExpendMnsLbbyngNonTxGrp

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Current Year Minus3$507,873CurrentYearMinus3Amt
Current Year Minus2$456,061CurrentYearMinus2Amt
Current Year Minus1$466,993CurrentYearMinus1Amt
Current Year$602,580CurrentYearAmt
Total$2,033,507TotalAmt
FieldValueIRS element (for citing)
Lobbying Ceiling$3,050,261LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$43,156CurrentYearMinus3Amt
Current Year Minus2$21,008CurrentYearMinus2Amt
Current Year Minus1$79,435CurrentYearMinus1Amt
Current Year$280,017CurrentYearAmt
Total$423,616TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Current Year Minus3$126,968CurrentYearMinus3Amt
Current Year Minus2$114,015CurrentYearMinus2Amt
Current Year Minus1$116,748CurrentYearMinus1Amt
Current Year$150,645CurrentYearAmt
Total$508,376TotalAmt
FieldValueIRS element (for citing)
Grassroots Ceiling$762,564GrassrootsCeilingAmt

Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$120CurrentYearMinus3Amt
Current Year Minus1$58,081CurrentYearMinus1Amt
Current Year$40,551CurrentYearAmt
Total$98,752TotalAmt

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Art Public Exhibition AmountsArtPublicExhibitionAmountsGrp
Held Works ArtHeldWorksArtGrp
CY Minus3 Yr Endwmt FundCYMinus3YrEndwmtFundGrp
CY Minus4 Yr Endwmt FundCYMinus4YrEndwmtFundGrp
LandLandGrp
BuildingsBuildingsGrp
Leasehold ImprovementsLeaseholdImprovementsGrp

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$154,338OtherCostOrOtherBasisAmt
Depreciation$118,513DepreciationAmt
Book Value$35,825BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$69,365OtherCostOrOtherBasisAmt
Depreciation$62,200DepreciationAmt
Book Value$7,165BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$42,990TotalBookValueLandBuildingsAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescCAPITAL LEASE OBGLIGATIONDesc
Amt$3,288Amt
FieldValueIRS element (for citing)
Total Liability$3,288TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$11,172,340TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst-$176,340NetUnrealizedGainsInvstAmt
Revenue Not Reported-$176,340RevenueNotReportedAmt
Revenue Subtotal$11,348,680RevenueSubtotalAmt
Other Revenues Not Included-$646,636OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt-$646,636RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$10,702,044TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$11,938,259TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included$646,636OtherExpensesIncludedAmt
Expenses Not Reported$646,636ExpensesNotReportedAmt
Expenses Subtotal$11,291,623ExpensesSubtotalAmt
Total Expenses Per Form990$11,291,623TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
SCHEDULE D, PART X, LINE 2:The Organization is exempt from income taxes under Section 501(c)(3) of the Internal Revenue Code ("IRC"), except for net income derived from unrelated business activities. In addition, the Organization qualifies for the charitable contribution deduction under Section 170(b)(1)(A) and has been classified as an organization other than a private foundation under IRC Section 509(a). The Organization's income tax filings are subject to audit by various taxing authorities. In evaluating the Organization's activities, management believes its position of tax-exempt status is based on current facts and circumstances and there have been no uncertain positions taken related to recording income taxes. It is the policy of the Organization to include in management and general expenses penalties and interest assessed by income taxing authorities. There were no penalties from taxing authorities included in management and general expenses for the year ended June 30, 2020.
Schedule D, Part XI, Line 4b - Other AdjustmentsSpecial Events: $(640,858) Sale of Goods: (5,778) Total: $(646,636)
Schedule D, Part XII, Line 2d - Other AdjustmentsSpecial Events: $640,858 Sale of Goods: 5,778 Total: $646,636

Schedule G IRS990ScheduleG

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1PFF WalksEvent1Nm
Gross Receipts Event1$767,510GrossReceiptsEvent1Amt
Charitable Contri Event1$767,510CharitableContriEvent1Amt
Rent Facility Costs Event1$1,500RentFacilityCostsEvent1Amt
Food And Beverage Event1$2,053FoodAndBeverageEvent1Amt
Entertainment Event1$4,195EntertainmentEvent1Amt
Other Direct Expenses Event1$393,646OtherDirectExpensesEvent1Amt
Event2Broadway BeltsEvent2Nm
Gross Receipts Event2$392,192GrossReceiptsEvent2Amt
Charitable Contri Event2$347,877CharitableContriEvent2Amt
Gross Revenue Event2$44,315GrossRevenueEvent2Amt
Food And Beverage Event2$67,228FoodAndBeverageEvent2Amt
Entertainment Event2$483EntertainmentEvent2Amt
Other Direct Expenses Event2$171,753OtherDirectExpensesEvent2Amt
Other Events Total0OtherEventsTotalCnt
Gross Receipts Total$1,159,702GrossReceiptsTotalAmt
Charitable Contributions Tot$1,115,387CharitableContributionsTotAmt
Gross Revenue Total Events$44,315GrossRevenueTotalEventsAmt
Rent Fclty Costs Total Events$1,500RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events$69,281FoodAndBeverageTotalEventsAmt
Entertainment Total Events$4,678EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events$565,399OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$640,858DirectExpenseSummaryEventsAmt
Net Income Summary-$596,543NetIncomeSummaryAmt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Recipient Table RecipientTable (6 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxtAddress Line2USAddress/AddressLine2Txt
Weill Medical College of Cornell University
1300 York AveNew YorkNY10065131623978501(c)(3)$50,000See Part IV
Trustees of the University of Pennsylvania
3451 Walnut StPhiladelphiaPA19104231352685501(c)(3)$50,000See Part IVFranklin Bldg P-221 Mailstop 6205
Weill Medical College of Cornell University
1300 York AveNew YorkNY10065131623978501(c)(3)$50,000See Part IV
Mayo Clinic
200 First St NWRochesterMN55905416011702501(c)(3)$50,000See Part IV
The Rector & Visitors of the Univ of VA
PO Box 400202CharlottesvilleVA22904546001796501(c)(3)$50,000See Part IV
UCSF
1855 Folsom StSan FranciscoCA94143946036493501(c)(3)$50,000See Part IVMCB 425 Box 0897
FieldValueIRS element (for citing)
Total501c3 Org6Total501c3OrgCnt

Supplemental Information Detail SupplementalInformationDetail (7 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule I, Part I, Line 2For larger grants, the Organization requests semi-annual reports detailing the use of grant funds from the recipient organizations.
Schedule I, Part II, Line 1(h) Purpose of Grant(1) SINGLE CELL RNA-SEQUENCING BASED CHARACTERIZATION OF BRONCHOALVEOLAR CELL POPULATIONS IN HYPERSENSITIVITY PNEUMONITIS Hypersensitivity pneumonitis (HP) can be difficult to diagnose and may be confused with other fibrotic lung conditions including idiopathic pulmonary fibrosis. This project will use a novel technology that measures gene expression in individual lung immune cells, obtained by performing a washing of the lung, to investigate the origin, nature and activation states of these cells. Additionally, the gene expression data will be used to identify a unique HP 'molecular signature' which can be used to differentiate the condition from other types of fibrotic lung disease.
Schedule I, Part II, Line 2(h) Purpose of Grant(2) PULMONARY FIBROSIS AS A DISEASE OF DISRUPTED EPITHELIAL PROTEOSTASIS AND CELL STRESS Mutations in the Surfactant Protein C (SFTPC) gene have been identified in a subset of patients with familial pulmonary fibrosis. These mutations result in misfolded proteins that activate epithelial cell stress pathways, providing an opportunity to study the pathway from cell stress to lung fibrosis. Using a recently published murine SFTPC mutant lung fibrosis model and primary human IPF cells from explanted lungs, the grant will address the central hypothesis that epithelial cell stress drives lung fibrosis by altering cell repair mechanisms. This work will provide mechanistic insight into IPF pathogenesis with the overall goal of identifying targetable upstream pathways.
Schedule I, Part II, Line 3(h) Purpose of Grant(3) THE DEVELOPMENT AND VALIDATION OF A DISEASE SPECIFIC HEALTH RELATED QUALITY OF LIFE INSTRUMENT FOR PATIENTS WITH CHRONIC HYPERSENSITIVITY PNEUMONITIS (CHP) Patients with CHP have variable clinical courses and the tests currently used to measure disease status, such as pulmonary function testing, are not the outcomes that are truly important to patients. As more CHP patients are enrolled in therapeutic trials, this grant proposes to develop a patient-centered outcome specific to CHP patients that comprehensively covers the aspects of quality of life that patients have identified as important in prior research. The proposed survey will offer a patient-centered perspective on disease severity and treatment effectiveness.
Schedule I, Part II, Line 4(h) Purpose of Grant(4) Targeting the HIPPO/YAP Pathway through G Protein-Coupled Receptors: A Viable Mechanism to Treat Pulmonary Fibrosis At the cellular level, one of the core contributors to pulmonary fibrosis are activated mesenchymal cells referred to as myofibroblasts. Recent studies have identified an important role for YAP and TAZ transcription factors in activating myofibroblasts in tissue fibrosis. It has recently been reported that G-protein coupled receptor (GPCR) activation can block nuclear localization and activity of YAP/TAZ. The grant hypothesizes that selectively activating these receptors in lung myofibroblasts will ablate the profibrotic effect of these cells in idiopathic pulmonary fibrosis (IPF). In support of this concept the grant will present preliminary data testing a small panel of GPCR ligands in lung fibroblasts and epithelial cells. The successful history of GPCR ligands as therapeutics has led to a highly translational approach to pursue this hypothesis.
Schedule I, Part II, Line 5(h) Purpose of Grant(5) ROLE OF POLYUNSATURATED FATTY ACIDS IN PULMONARY FIBROSIS There is a desperate need for new treatments as modifiable risk factors may be targets for therapy that improve outcomes for patients. Using the Pulmonary Fibrosis Foundation Registry and Biorepository, this grant will to examine whether higher omega-3 intake is associated with better lung function and exercise capacity in adults with pulmonary fibrosis. It will examine mechanisms that may be driving these associations including whether omega-3 fatty acids slow accelerated aging which is a key characteristic of pulmonary fibrosis.
Schedule I, Part II, Line 6(h) Purpose of Grant(6) CLOSING THE EVIDENCE GAP IN ILD: THE USE OF REAL WORLD OBSERVATIONAL COHORTS TO UNDERSTAND THE NATURAL HISTORY OF FIBROTIC LUNG This grant will develop a model for integrating clinical research into routine clinical care in order to generate evidence that is applicable to diverse, real-world patient populations and aligned with the clinical questions that are priorities for patients, caregivers and providers. The grant proposes to harness the robust patient-level and health system level information continuously generated and captured in the electronic health record, to study the association between predictors and outcomes, which can be used to develop best practices in ILD care.

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Housing Allowance Or ResidenceYes (X)HousingAllowanceOrResidenceInd
Written Policy Ref T And E ExpnssfalseWrittenPolicyRefTAndEExpnssInd
Substantiation RequiredfalseSubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Written Employment ContractYes (X)WrittenEmploymentContractInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentfalseSeverancePaymentInd
Supplemental Nonqual Rtr PlanfalseSupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsfalseAnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (7 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
William T Schmidt
Director/President and CEO$365,209$0$0$0$0$0$25,000$0$2,650$0$392,859$0$0$0
Scott Staszak
Chief Operating Officer$260,064$0$0$0$0$0$19,000$0$0$0$279,064$0$0$0
Laura Sadler
Chief Marketing Officer$172,997$0$0$0$0$0$0$0$9,619$0$182,616$0$0$0
Pauline Bianchi
Senior VP, Research & Programs$210,160$0$0$0$0$0$25,000$0$1,927$0$237,087$0$0$0
Kerrie Trebonsky
VP, Finance$131,368$0$0$0$0$0$9,157$0$21,236$0$161,761$0$0$0
Rex Edwards
VP, CCN & PFF Patient Registry$144,586$0$0$0$0$0$12,532$0$3,693$0$160,811$0$0$0
Seth Klein
Sr Director, Development Ops$145,227$0$0$0$0$0$7,630$0$5,873$0$158,730$0$0$0

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule J, Part I, Line 1aCEO RESIDES IN MD AND CANNOT RELOCATE AT THIS TIME, HOWEVER, HE NEEDS TO SPEND SUBSTANTIAL TIME IN CHICAGO AND THEREFORE PFF AGREED TO PROVIDE A HOUSING ALLOWANCE.
Schedule J, Part I, Line 1bDETAILS ARE DISCLOSED IN CEO'S EMPLOYMENT CONTRACT. WE DO NOT OFFER THIS ARRANGEMENT TO OTHER STAFF MEMBERS AND THUS DO NOT HAVE A WRITTEN POLICY FOR A HOUSING ALLOWANCE.

Schedule M IRS990ScheduleM

FieldValueIRS element (for citing)
Works Of ArtWorksOfArtGrp
Art Historical TreasuresArtHistoricalTreasuresGrp
Art Fractional InterestArtFractionalInterestGrp
Books And PublicationsBooksAndPublicationsGrp
Clothing And Household GoodsClothingAndHouseholdGoodsGrp
Cars And Other VehiclesCarsAndOtherVehiclesGrp
Boats And PlanesBoatsAndPlanesGrp
Intellectual PropertyIntellectualPropertyGrp

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution6ContributionCnt
Noncash Contributions Rpt F990$1,965,178NoncashContributionsRptF990Amt
Method Of Determining RevenuesFMVMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Securities Closely Held StockSecuritiesCloselyHeldStockGrp
Secur Prtnrshp Trust IntrstsSecurPrtnrshpTrustIntrstsGrp
Securities MiscellaneousSecuritiesMiscellaneousGrp
Qualified Contrib Hist StructQualifiedContribHistStructGrp
Qualified Contrib OtherQualifiedContribOtherGrp
Real Estate ResidentialRealEstateResidentialGrp
Real Estate CommercialRealEstateCommercialGrp
Real Estate OtherRealEstateOtherGrp
CollectiblesCollectiblesGrp
Food InventoryFoodInventoryGrp
Drugs And Medical SuppliesDrugsAndMedicalSuppliesGrp
TaxidermyTaxidermyGrp
Historical ArtifactsHistoricalArtifactsGrp
Scientific SpecimensScientificSpecimensGrp
Archaeological ArtifactsArchaeologicalArtifactsGrp

Other Non Cash Contri Table OtherNonCashContriTableGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
DescOtherDesc
Contribution1ContributionCnt
Noncash Contributions Rpt F990$335NoncashContributionsRptF990Amt
Method Of Determining RevenuesFMVMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Any Property That Must Be HeldfalseAnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (true)ReviewProcessUnusualNCGiftsInd
Third Parties UsedfalseThirdPartiesUsedInd

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (30 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
CONTINUED FROM FORM 990, PART III, LINE 4A:and other disease awareness and education programs. During the fiscal year, the PFF accepted 14 new PFF Ambassadors into the programs. These Ambassadors consist of pulmonary fibrosis patients, caregivers, lung transplant recipients, and those who lost a loved one to the disease. PFF Ambassadors spoke at 34 in-person events including Support Group meetings, educational conferences and fundraisers and had over a dozen virtual opportunities as society shifted during COVID-19. The PFF Daughters Program was founded to expand awareness of pulmonary fibrosis, especially among policymakers, via grassroots events and fundraisers across the nation, in order to generate a broader understanding of the impact the disease has on those living with PF and their families. The PFF Daughters program is now the PFF Advocates, with more than 1,000 members. Pulmonary Fibrosis Awareness Month (September) is when the PF community unites as a collective voice to enhance disease awareness and provide outreach to those in need. During Pulmonary Fibrosis Awareness Month, the PF community joined the PFF and participated in the #BlueUp4PF campaign, attended educational events, hosted Team PFF fundraising events, participated in webinars and spread disease awareness through social media. More Than A Cough Campaign: In September 2019, the Pulmonary Fibrosis Foundation (PFF) and Three Lakes Foundation (TLF) joined forces to launch a new partnership to combat PF. The "More Than A Cough" (MTAC) campaign was created to drive public awareness of pulmonary fibrosis (PF) and was a key piece of this effort. The innovative multi-channel MTAC campaign, which ran through April 2020, featured two animated characters, Norm and Jennifer, designed to illustrate the experiences of patients and caregivers. They were introduced via digital, social media, broadcast, and print advertisements in Chicago followed by a Google campaign in the test markets of Birmingham, Scottsdale, and Nashville. MTAC produced over 62 million impressions, 432,000 visitors to the MTAC landing page, and 53,000 downloads of the pulmonary fibrosis risk list. The campaign achieved a 576% increase in the search term "pulmonary fibrosis" in Chicago alone.
CONTINUED FROM FORM 990, PART III, LINE 4B:independently managed by a data coordinating center. The Registry also collects biological specimens that patients have agreed to give, which are deidentified and independently managed by a medical specimen storage facility associated with the data coordinating center. The Registrys key aims are to: (1) conduct benchmarking and quality improvement efforts across the PFFs medical center network; (2) develop a more representative understanding of PF patient in the United States; (3) facilitate research in identified priority areas; and (4) increase the PFFs reach within the PF community. As of June 30, 2020, the Registry has activated 42 sites and identified 2,003 patients for enrollment. This vital program is completing its first phase and will embark on the next phase to continue to capture clinical patient information and expand into the community to collect information from other patients, lung transplant recipients, caregivers, and families. This will provide a more representative understanding of the PF community and create a robust pool of engaged community members for advocacy, clinical trials, and other research. To learn more about the PFF Patient Registry, please go to: http://bit.ly/pffregistry.
CONTINUED FROM FORM 990, PART III, LINE 4C:The PFF Summit features an innovative continuing medical education (CME) program for Health Care Professionals and sessions for PF patients and caregivers that address their growing educational needs. (Note: Some expenses for the PFF Summit 2019 were included in the 2018 Form 990).
FORM 990, PART III, LINE 4D:1. Marketing: Activities were first concentrated during September, October, and November to leverage exposure offered by Pulmonary Fibrosis Awareness Month (September) and through the PFF Summit (November). In January, we commissioned a first of its kind national survey to measure public awareness of PF. The online survey was administered to 2,103 adults nationwide and we found that 86% of Americans do not know the symptoms of PF. The survey announcement was followed by a satellite media tour with TV and radio stations across the U.S. to drive awareness of PF. On Feb. 27, Dr. Cosgrove conducted 20 interviews with television and radio stations across the country. Using Rare Disease Awareness Week as a story driver, he described the symptoms and risk factors of PF and encouraged the audience to visit AboutPF.org or discuss the disease with their physician. We also recorded and distributed an audio news release to radio stations nationwide. These activities overall continued to increase awareness of PF and its risk factors nationwide, generating more than 515.1 million impressions and successfully grew traffic to the AboutPF.org microsite and to the PFF's website, pulmonaryfibroisis.org. Inquiries to the PFF's Patient Communication Center (PCC) also grew as a result of the campaign. Constituencies served by the marketing campaign extension in traditional and digital media included patients and potential patients; caregivers and families; healthcare providers; at-risk populations. 2. Education: The Pulmonary Fibrosis Foundation (PFF) is committed to providing quality disease education to the pulmonary fibrosis community. The PFF strives to provide patients, caregivers, family members, and health care providers with the resources necessary to more fully understand PF, and to provide patients with the tools necessary to live with the disease and improve their quality of life. The Foundation created a variety of new materials and resources for the PF community in fiscal year 2019-2020. Printed materials included the PF Family and Friends Postcards. The PFF Oxygen Basics Booklet was translated to Spanish. The following materials were updated to include new PFF resources and reflect new treatment information due to medication label expansions: Pulmonary Fibrosis Information Guide (and translations), ILD Nursing and Allied Health Guide, Nintedanib Fact Sheet, Pirfenidone Fact Sheet, Scleroderma-Associated ILD Fact Sheet, PF Clinical Trial Postcard, and About PFF Brochure. Printed educational materials are distributed through the PFF Patient Communication Center and at education events and conferences. The PFF developed guidance and FAQ documents about COVID-19 and curated a list of relevant resources related to COVID-19 to provide reliable information about the pandemic to members of the PF community. The PFF also produced two videos about COVID-19 titled "PFF COVID-19 Guidance"COVID-19 Everyday Precautions." The PFF added a new patient story video to the Life with Pulmonary Fibrosis series in English and Spanish. Additionally, the PFF produced a new series of short videos titled "Words of Wisdom" which provides perspectives and advice from caregivers in the PF community. These videos can be found on the Foundation's YouTube channel. The PFF Disease Education Webinar Series engages the PF community in an online webinar discussion where they learn from, connect with, and pose questions to leading pulmonary fibrosis specialists each month. Ten webinars were presented in fiscal year 2019-20 and all can be viewed on the PFF website at https://bit.ly/pffwebinars and on the Foundation's YouTube channel. Topics addressed during this time period include idiopathic interstitial lung diseases, supplemental oxygen, treatment options, PF research, occupational PF, and COVID-19.
3. PFF Care Center NetworkThe Pulmonary Fibrosis Foundation (PFF) is dedicated to promoting earlier recognition and diagnosis of pulmonary fibrosis and ensuring that patients receive the highest quality healthcare. As part of that commitment, over the past three years the PFF has worked with the PF medical community to establish the PFF Care Center Network (CCN), where people with PF can find experienced medical professionals who understand their disease and support services to improve the quality of their lives. The goals of the PFF CCN is to deliver state of the art, patient-centered care; to disseminate education to support our patients, caregivers and providers; to give voice to the needs of our community through advocacy and fundraising; and to accelerate research in PF both directly and through collaborations and networking. The CCNs programmatic service accomplishments are highlighted below. The PFF Medical team has developed a new PFF CCN Annual Report to all 68 care centers. This center based report will have a strong emphasis on benchmarking, research, clinical care, community-based clinical support, and patient satisfaction. We anticipate that with this data centric approach we will be better positioned to understand the unique characteristics within our network. The Palliative Care Services in Care Centers Survey working group strived for 100% Care Center participation with an estimated 136 survey responses. The aim of this survey is to understand the role of palliative care services, perspectives and current resources available to providers who care for patients with pulmonary fibrosis and interstitial lung disease. The survey was disseminated to physicians, advance practice providers, nurses, respiratory therapists, and social workers who care for ILD patients at the 68 PFF Care Centers. Interstitial lung disease (ILD) causes a profound symptom burden and carries a high mortality. Palliative care is dedicated to improving quality of life and empowering patients in advance care planning. Early integration of Palliative Care in ILD improves the rates of advance care planning and symptomatic management. Knowledge of ILD provider perspectives on Palliative Care is key to improving care delivery to ILD patients. Descriptive statistics will be compiled for survey responses in the next fiscal year. The Survey for PFF Care Centers During the 2020 COVID-19 Pandemic was conducted by the PFF Care Center Network. The purpose of this survey is to gather center based information on the impact of the coronavirus disease (COVID-19) by developing functioning strategies for clinical trial networks in the event of the next surge or other event making physical visits not possible. The results from this survey will only be used for academic research in order to allow the PFF to move health initiatives and advocacy recommendations measures forward. Key research initiatives such as these we will make an impact in promoting earlier recognition and diagnosis of pulmonary fibrosis and ensuring that patients receive the highest quality healthcare. 4. Advocacy: During the year, the PFF engaged policymakers in advocating for increased funding for pulmonary fibrosis research and improved access to oxygen for patients. The PFF hosted a virtual Hill Day in March to allow constituents to speak with their members of Congress about the impact of pulmonary fibrosis in their lives and the need for research funding. The PFF successfully asked the Centers for Medicare and Medicaid Services to waive the in-person testing requirements for oxygen certification during the public health emergency caused by COVID-19. The PFF provided training to grassroots advocates on meeting with their lawmakers to advocate for the needs of the community.
5. Research GrantsThe Pulmonary Fibrosis Foundation (PFF) places enormous importance on creating an environment that will assist in the development of effective treatments for pulmonary fibrosis (PF). The PFF Scholars Program supports projects that offer a high likelihood of improving the understanding of PF in the following research areas: basic science, translational, clinical, epidemiological, and health services. The goal of the PFF Scholars Program is to support emerging investigators to advance research that could translate into successful therapies, while also enabling these promising researchers to obtain dependent funding and continue their cutting-edge research. The Research Review Committee administers the peer-reviewed process, which funds six $50,000 grants per cycle. The PFF also considers other smaller grants that fit the research guidelines. 6. Support Groups: The PFF Support Group Leader Network provides a forum for PF support group leaders to connect, exchange ideas, and share best practices. The PFFs Support Group Network consists of over 140 support groups across the country. During the public health emergency caused by COVID-19, many groups have been meeting virtually, with support from the PFF. Online Support Group communities are a great way for patients, caregivers, family members, and friends to virtually connect for support and information. For those who are unable to attend an in-person group, or simply want additional interactions between meetings, the Pulmonary Fibrosis Foundation offers two telephone-based support groups: PFF Voices and Caring Conversations. In addition, the PFF has added Coloquio, a Spanish-language telephone support group. These groups meet once per month over the phone in a conference call setting. Each monthly meeting provides a chance to discuss different topics related to pulmonary fibrosis, share personal stories, ask questions and provide support to one another. Visit http://bit.ly/pffsupport to learn more. 7. PFF Patient Communication Center (PCC): The PFF Patient Communication Center (PCC) serves as the central information hub for pulmonary fibrosis patients, caregivers, the Support Group Leader Network (see Support Group section), and health care professionals. The PCC staff provides general information about pulmonary fibrosis that is tailored to individuals needs and answers questions about the availability of support services and other essential resources. Resources available include: information on PFF programs, educational and advocacy materials, how to find medical care and support groups, access to support services, information about available treatments, and how to find clinical trials. The Foundation continuously surveys the PF community to determine additional educational materials or translations of current materials that are needed and works to develop those materials to fit unmet needs in the community. The Foundation also facilitates physician education by providing materials through the Patient Communication Center and at educational conferences. The Foundation maintains an Oxygen Information Line to provide patients and caregivers with general information on accessing and safely using supplemental oxygen. In fiscal year 2019-2020, the Patient Communication Center received 4,647 inquiries via telephone and email.
FORM 990, PART VI, SECTION B, LINE 11B:A COPY OF FORM 990 IS REVIEWED BY THE FINANCE COMMITTEE BEFORE FILING. THE FORM 990 IS AVAILABLE TO ALL BOARD MEMBERS BEFORE FILING THE FORM.
FORM 990, PART VI, SECTION B, LINE 12C:THE ORGANIZATION HAS A CONFLICT OF INTEREST POLICY WITHIN THE EMPLOYEE HANDBOOK AND ALL EMPLOYEES ARE REQUIRED TO ADHERE TO THE POLICY. EMPLOYEES SIGN A DISCLOSURE FORM EACH YEAR. ANNUALLY, BOARD MEMBERS ARE SENT A FORM TO FILL OUT STATING WHETHER THEY HAVE ANY CONFLICTS OF INTEREST. IF SUCH CONFLICTS EXIST, THEN THEY FILL OUT AN ADDITIONAL FORM OUTLINING THOSE CONFLICTS. THE EXECUTIVE COMMITTEE REVIEWS ANY CONFLICTS THAT ARISE.
FORM 990, PART VI, SECTION B, LINES 15A & B:CHIEF EXECUTIVE OFFICER AND CHIEF OPERATING OFFICER'S COMPENSATION WAS APPROVED BY THE EXECUTIVE COMMITTEE, WHICH SERVES AS THE COMPENSATION COMMITTEE. THIS APPROVAL WAS BASED ON A REVIEW BY AN INDEPENDENT COMPENSATION CONSULTANT AND IS SUPPORTED BY A WRITTEN EMPLOYMENT CONTRACT. THE COMMITTEE ALSO REVIEWED COMPENSATION SURVEYS AND FORM 990S OF OTHER ORGANIZATIONS TO ENSURE THE COMPENSATION WAS APPROPRIATE. THE SALARY FOR THE CHIEF MARKETING OFFICER WAS NOT REVIEWED BY THE COMPENSATION COMMITTEE, BUT THE SALARY WAS IN LINE WITH THE MARKET.
FORM 990, PART VI, SECTION C, LINE 19:THE ORGANIZATION MAKES ITS FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST AND ON THE ORGANIZATION'S WEBSITE. THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY AVAILABLE TO THE PUBLIC.
FORM 990 PART IX LINE 11GDESCRIPTION:MARKETING CONSULTING TOTAL FEES:2290214
FORM 990 PART IX LINE 11GDESCRIPTION:SITE PAYMENTS TOTAL FEES:894926
FORM 990 PART IX LINE 11GDESCRIPTION:REGISTRY DCC CONSULTING TOTAL FEES:340612
FORM 990 PART IX LINE 11GDESCRIPTION:OTHER CONSULTING TOTAL FEES:335191
FORM 990 PART IX LINE 11GDESCRIPTION:MEDICAL CONSULTING TOTAL FEES:322143
FORM 990 PART IX LINE 11GDESCRIPTION:REGISTRY CONSULTING TOTAL FEES:166965
FORM 990 PART IX LINE 11GDESCRIPTION:CME TOTAL FEES:72250
FORM 990 PART IX LINE 11GDESCRIPTION:RECRUITMENT FEES TOTAL FEES:54665
FORM 990 PART IX LINE 11GDESCRIPTION:MERCHANT CARD CHARGES TOTAL FEES:48980
FORM 990 PART IX LINE 11GDESCRIPTION:STIPENDS TOTAL FEES:22625
FORM 990 PART IX LINE 11GDESCRIPTION:INVESTMENT FEES TOTAL FEES:21776
FORM 990 PART IX LINE 11GDESCRIPTION:MEDIA RELATIONS TOTAL FEES:19685
FORM 990 PART IX LINE 11GDESCRIPTION:COLLECTION KIT TOTAL FEES:19650
FORM 990 PART IX LINE 11GDESCRIPTION:GRAPHIC DESIGN TOTAL FEES:19500
FORM 990 PART IX LINE 11GDESCRIPTION:IT CONSULTING TOTAL FEES:15897
FORM 990 PART IX LINE 11GDESCRIPTION:EMPLOYEE ADMINISTRATION FEES TOTAL FEES:13496
FORM 990 PART IX LINE 11GDESCRIPTION:OTHER OUTSIDE SERVICES TOTAL FEES:13160
FORM 990 PART IX LINE 11GDESCRIPTION:WRITING/EDITING TOTAL FEES:3660
FORM 990 PART IX LINE 11GDESCRIPTION:PHOTOGRAPHY TOTAL FEES:2240
FORM 990 PART IX LINE 11GDESCRIPTION:REGISTRY HRCT CONSULTING TOTAL FEES:-6989

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.